Trials / Completed
CompletedNCT01655303
Rate Control in Atrial Fibrillation
Oral Propranolol, Diltiazem, Metoprolol and Verapamil in Atrial Fibrillation Rate Control in Patients With Stable Hemodynamic Status
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Rate control in atrial fibrillation is a usual battle in emergency departments. Oral medications have a natural superiority to intravenous ones because they are easy-to-use and decrease the workload in busy emergency departments. This study wants to find an effective oral medication for rate control in rapid ventricular response atrial fibrillation. Propranolol and Metoprolol, Diltiazem and Verapamil are compared in patients with a stable hemodynamic status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propranolol | |
| DRUG | Metoprolol | |
| DRUG | Verapamil | |
| DRUG | Diltiazem |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2012-08-01
- Last updated
- 2012-08-01
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01655303. Inclusion in this directory is not an endorsement.